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Background: Aortic valve calcification (AVC) secondary to renal failure is an inflammatory regulated process involving apoptotic features 
considered essential for calcification. We sought to assess the role of apoptosis during AVC development using our unique animal model of renal 
failure associated AVC both in-vivo and in-vitro.
Methods: Aortic valves were obtained from rats fed exclusively with a high-adenine (0.75%), high-phosphate (1.5%) uremia-inducing diet for 2, 3, 
4, 5, and 6 weeks (8 rats in each time period). Calcification and apoptosis markers were evaluated at different phases of the calcification process. 
Evaluation included Von-Kossa staining for calcium nodules, western blot analysis for caspase 3 expression (apoptosis marker), and TUNEL staining 
for apoptotic bodies.  In order to better define the role of apoptosis inhibition, we used an in vitro system of aortic valve interstitial cell in which 
calcification was induced by high phosphate. We pre-treated the cells with Z-VAD-FMK- a permanent caspase inhibitor- then assessed mineralization 
and osteoblast markers in these cells.
Results: Calcification of aortic valves was noticed only after 6 weeks of diet with no calcification observed earlier. Up regulation of caspase 3 was 
demonstrated only in calcified valves. Similarly, TUNEL staining demonstrated apoptotic bodies only in calcified areas. No apoptotic markers were 
observed before calcification was noticed. In-vitro assessment showed that phosphate treatment induced calcification, while inhibition of apoptosis 
by Z-VAD-FMK did not alter the calcification process. Moreover, osteoblast markers remained unchanged in cells pretreated with Z-VAD-FMK.
Conclusions: Apoptosis accompanies calcification in renal failure associated AVC and occurs only after calcification is already noticed. Inhibition 
of apoptosis does not effect either the calcification or osteoblast transformation.  These novel observations suggest that apoptosis is not the cause 
of calcification, therefore medical approaches targeting apoptosis might be ineffective in preventing AVC. Further studies are required to define the 
causality relationship between calcification and apoptosis. 
